Physician Assistant · Ann Arbor, MI
NPI
1114015187
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 E Medical Center Dr, B1 Floor Cancer Center Recp B
Ann Arbor, MI, 48109
Phone (734) 936-9814
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
267 services
Medicare patients, 2024
63
Average age 65
Drug cost, 2024
$2.6M
1,323 prescriptions
Company payments, 2025
$409
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adrienne P Trentacosti was code 99215 (office e&m - established), 149 times for 46 patients. In total Adrienne P Trentacosti billed 267 services in 10 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 149 | 46 | $92.40 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 81 | 28 | $11.03 | $894 |
| 38222 Other Organ Systems | Facility | 21 | 18 | $46.15 | $969 |
By year: 2022 $12K for 149 services; 2023 $16K for 185 services; 2024 $17K for 267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adrienne P Trentacosti prescribed most often to Medicare patients was Acyclovir, with 188 prescriptions and refills. In total Adrienne P Trentacosti wrote 1,323 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 188 | 346 | 47 | $3,948 |
| Jakafi Ruxolitinib Phosphate | 118 | 120 | 26 | $1.8M |
| Posaconazole Generic | 105 | 105 | 15 | $160K |
| Ursodiol Generic | 82 | 124 | 21 | $7,198 |
| Prednisone Generic | 79 | 109 | 20 | $1,460 |
| Azithromycin Generic | 45 | 53 | 13 | $456 |
| Montelukast Sodium Generic | 37 | 65 | Under 11 | $414 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 35 | 70 | 11 | $480 |
| Valacyclovir Valacyclovir Hcl | 32 | 46 | Under 11 | $1,111 |
| Atovaquone Generic | 29 | 37 | Under 11 | $20K |
| Cresemba Isavuconazonium Sulfate | 25 | 25 | Under 11 | $157K |
| Amlodipine Besylate Generic | 24 | 29 | Under 11 | $81.78 |
| Famotidine Generic | 22 | 34 | Under 11 | $120 |
| Prevymis Letermovir | 21 | 21 | Under 11 | $144K |
| Rosuvastatin Calcium Generic | 18 | 22 | Under 11 | $152 |
Brand drugs: - claims; generic drugs: 1,030 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adrienne P Trentacosti $409 ($409 in general payments such as food, travel and fees) from 1 company. The largest payer was Bard Peripheral Vascular, Inc. with $409.
| Company | Payments | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. BDX | 1 | $409 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.